NEW YORK (GenomeWeb) – German sample preparation firm Scienion and Applied Microarrays announced today that they have signed a deal to jointly offer their services and equipment solutions for the development, high-volume manufacture, and launch of multiplexed in vitro diagnostics.
Specific terms of the arrangement were not disclosed.
"Many of our customers already work with both our companies," Scienion CEO Holger Eickhoff said in a statement. "This partnership will enable those and future joint customers to interact and communicate seamlessly during development and manufacturing."
AMI CEO Alastair Malcolm added that the deal with Scienion is expected to support his company's efforts to extend its DNA and protein microarray design, optimization, and manufacturing services to additional steps in its customers' product develop and supply processes.